Shanghai Shinechi Medical's Qili®S PRipper®S Peripheral Cutting Balloon Receives NMPA Approval

Recently, Shanghai Shenqi Medical Technology Co., Ltd. (hereinafter referred to as“Shenqi Medical^®”) Independently developed byQi Li^®S PRipper^®S Peripheral Cutting Balloon, officially received the approval from the National Medical Products Administration (NMPA) Approved for marketing, Registration No.: National Medical Device Approval 20263030952。

Qi Li^®S PRipper^®S Peripheral Cutting Balloon is Rapid Exchange Type (Rx Type) Balloon dilation catheter, with longitudinal grooves on the balloon surface3Group or4Stainless steel blade assembly, with a hydrophilic coating design on the distal end of the catheter. This product is suitable for treating lesions in the femoral artery, popliteal artery, infrapopliteal artery, and renal artery. It can also be used for the treatment of obstructive lesions in autologous or artificial arteriovenous dialysis fistulas. Target lesions must meet the following criteria: low curvature in the proximal vessel segment, non-angled lesion segment with angulation not exceeding45°; Applicable target lesion vessel diameter range is2–4mm。

Ji Qi Li^®PRipper^® Peripheral Cutting Balloon (Balloon Diameter5–8mm) After being approved for marketing, this time Qi Li^®S PRipper^®S(Balloon Diameter2–4mm) has been successfully approved, marking that Shenqi Medical's peripheral cutting balloon has achieved balloon diameter2mmTo8mmFull Specification Coverage, providing a one-stop, precision cutting and dilation solution for peripheral vascular lesions of different diameters, further enhancing the company's peripheral intervention product portfolio and comprehensively improving clinical compatibility and application value.

As a medical enterprise rooted in China, Shenqi Medical adheres to the concept of "Innovation · Heart Protection" and always takes "better meeting the rapidly growing healthcare needs of the Chinese market" as its mission. By developing innovative and high-quality cardiac and vascular interventional products, it provides comprehensive solutions in the field of cardiovascular disease treatment, benefiting more patients in China. In the future, Shenqi Medical will position and develop its products for the global market, actively participate in global competition in related fields, and commit to launching more high-quality and advanced medical device products to provide more comprehensive disease treatment solutions for patients both domestically and internationally.